Effectiveness of pulmonary rehabilitation on severe asthma outcomes: a pre-post study

<bold>Background:</bold> In severe asthma, pulmonary rehabilitation (PR) is effective for improving exercise capacity and quality of life but its effect on asthma control, risk of severe exacerbations and glucocorticoids exposure is unknown. <bold>Objective:</bold> To investigate the effect of PR on asthma control, rate of severe exacerbations and glucocorticoids use as well as hyperventilation, anxiety and depression symptoms in severe asthma. <bold>Methods:</bold> In a retrospective study, we included all patients with severe asthma referred for a PR program. Changes in the Asthma Control Test (ACT), Nijmegen questionnaire and Hospital Anxiety and Depression scale (HADs) from baseline (M0) to end of PR (M2), 6 and 12 months after PR (M8 and M14) were evaluated using a mixed linear model or pairwise Wilcoxon signed rank tests in case of non-Gaussian distribution. The annual rate of severe exacerbations and the annual cumulative dose of glucocorticoids were compared between the year after and before PR. <bold>Results:</bold> We included 50 patients (78% women, age 59 [46-65] years, FEV1 53% [38.5-86]). Median ACT score increased from 11 [8-16] to 13.5 [10-18.5] at M2 (p<0.001), 14 [10-18] at M8 (p=0.021), and 15 [9.5-19] at M14 (p=0.045). In the year following PR, the median rate of severe exacerbations decreased from 3 [1-6] to 1.5 [0-4.5] (p=0.007) and the median cumulative dose of glucocorticoids from 2240mg [250-5040] to 1200mg [0-4290] (p=0.001). <bold>Conclusion:</bold> Our results suggest an improvement of severe asthma control in a substantial number of patients and a reduction of future risks after PR, advocating that PR could be a part of the treatment of severe asthma beyond the management of respiratory disability.

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa4120
Primary Topic
Health and Well-being Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of pulmonary rehabilitation on severe asthma outcomes: a pre-post study

Jean‐Marie Grosbois, Émilie Margoline, Sarah Géphine, Olivier Le Rouzic et al.
Health and Well-being Studies
article

Effectiveness of pulmonary rehabilitation on severe asthma outcomes: a pre-post study

Jean‐Marie Grosbois, Émilie Margoline, Sarah Géphine, Olivier Le Rouzic, Émeline Cailliau, Stéphanie Fry, Cécile Chenivesse
article en

Abstract

<bold>Background:</bold> In severe asthma, pulmonary rehabilitation (PR) is effective for improving exercise capacity and quality of life but its effect on asthma control, risk of severe exacerbations and glucocorticoids exposure is unknown. <bold>Objective:</bold> To investigate the effect of PR on asthma control, rate of severe exacerbations and glucocorticoids use as well as hyperventilation, anxiety and depression symptoms in severe asthma. <bold>Methods:</bold> In a retrospective study, we included all patients with severe asthma referred for a PR program. Changes in the Asthma Control Test (ACT), Nijmegen questionnaire and Hospital Anxiety and Depression scale (HADs) from baseline (M0) to end of PR (M2), 6 and 12 months after PR (M8 and M14) were evaluated using a mixed linear model or pairwise Wilcoxon signed rank tests in case of non-Gaussian distribution. The annual rate of severe exacerbations and the annual cumulative dose of glucocorticoids were compared between the year after and before PR. <bold>Results:</bold> We included 50 patients (78% women, age 59 [46-65] years, FEV1 53% [38.5-86]). Median ACT score increased from 11 [8-16] to 13.5 [10-18.5] at M2 (p<0.001), 14 [10-18] at M8 (p=0.021), and 15 [9.5-19] at M14 (p=0.045). In the year following PR, the median rate of severe exacerbations decreased from 3 [1-6] to 1.5 [0-4.5] (p=0.007) and the median cumulative dose of glucocorticoids from 2240mg [250-5040] to 1200mg [0-4290] (p=0.001). <bold>Conclusion:</bold> Our results suggest an improvement of severe asthma control in a substantial number of patients and a reduction of future risks after PR, advocating that PR could be a part of the treatment of severe asthma beyond the management of respiratory disability.

Centre National de la Recherche Scientifique (FR), Inserm (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Lille’s Cardiology Hospital (FR), Santé Publique France (FR), Center for Infection and Immunity of Lille (FR)
Good health and well-being
Openalex Percentile: Top 72%
Health and Well-being Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.